Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Almeida

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Epilepsia|August 14, 2012
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studiesAntónio Gil-Nagel, Christian Elger, Elinor Ben-Menachem, et al.
Current Medical Research and Opinion|March 16, 2010
Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitorLuis Almeida, Ana I Loureiro, Manuel Vaz-da-Silva, et al.
European Heart Journal. Acute Cardiovascular Care|June 16, 2017
Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcomeSilvia Aguiar Rosa, Ana Teresa Timóteo, Lurdes Ferreira, et al.
European Journal of Clinical Pharmacology|August 6, 2008
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsLuis Almeida, Amílcar Falcão, Manuel Vaz-da-Silva, et al.
British Journal of Clinical Pharmacology|January 23, 2013
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjectsJosé Francisco Rocha, Luis Almeida, Amílcar Falcão, et al.
Toxins|August 26, 2021
The Natterin Proteins Diversity: A Review on Phylogeny, Structure, and Immune FunctionCarla Lima, Geonildo Rodrigo Disner, Maria Alice Pimentel Falcão, et al.
Clinical Pharmacokinetics|December 19, 2012
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitorLuis Almeida, José Francisco Rocha, Amílcar Falcão, et al.
Journal of Bioenergetics and Biomembranes|November 18, 2017
Plants of Brazilian restingas with tripanocide activity against Trypanosoma cruzi strainsRobson Xavier Faria, André Luis Almeida Souza, Barbara Lima, et al.
Plos One|August 7, 2008
Surfactants as microbicides and contraceptive agents: a systematic in vitro studyOtilia V Vieira, Diego O Hartmann, Carla M P Cardoso, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2004
Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular riskFlávio Reis, Maria Vitor Campos, Margarida Bastos, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Epilepsia|August 14, 2012
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studiesAntónio Gil-Nagel, Christian Elger, Elinor Ben-Menachem, et al.
Current Medical Research and Opinion|March 16, 2010
Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitorLuis Almeida, Ana I Loureiro, Manuel Vaz-da-Silva, et al.
European Heart Journal. Acute Cardiovascular Care|June 16, 2017
Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcomeSilvia Aguiar Rosa, Ana Teresa Timóteo, Lurdes Ferreira, et al.
European Journal of Clinical Pharmacology|August 6, 2008
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsLuis Almeida, Amílcar Falcão, Manuel Vaz-da-Silva, et al.
British Journal of Clinical Pharmacology|January 23, 2013
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjectsJosé Francisco Rocha, Luis Almeida, Amílcar Falcão, et al.
Toxins|August 26, 2021
The Natterin Proteins Diversity: A Review on Phylogeny, Structure, and Immune FunctionCarla Lima, Geonildo Rodrigo Disner, Maria Alice Pimentel Falcão, et al.
Clinical Pharmacokinetics|December 19, 2012
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitorLuis Almeida, José Francisco Rocha, Amílcar Falcão, et al.
Journal of Bioenergetics and Biomembranes|November 18, 2017
Plants of Brazilian restingas with tripanocide activity against Trypanosoma cruzi strainsRobson Xavier Faria, André Luis Almeida Souza, Barbara Lima, et al.
Plos One|August 7, 2008
Surfactants as microbicides and contraceptive agents: a systematic in vitro studyOtilia V Vieira, Diego O Hartmann, Carla M P Cardoso, et al.
The Journal of Clinical Endocrinology and Metabolism|October 21, 2004
Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular riskFlávio Reis, Maria Vitor Campos, Margarida Bastos, et al.
Pageof 14